Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.

Biotechnology

Health Care

Life Sciences

Therapeutics

Crossbow Therapeutics, Inc

Briggs Morrison

Vinutha Chandrababu

Tao Wang

Bhupal Ban

Benjamin Lee

Amanda Mak

Dmitri Wiederschain

Scientific Research and Development

Leadership Team

Teams at Crossbow Therapeutics, Inc

Scientific Research and Development

Leadership Team